April 11, 2013
ArcDia International Ltd, the manufacturer of world's only multianalyte point-of-care diagnostic system for respiratory tract infections, is pleased to announce the strengthening of its management team and customer operations with the appointment of
Jesper Floyd Kristiansen
as VP Sales and Marketing.
Prior the appointment, Mr. Kristiansen held various management positions at Dako, the leading company for cancer diagnostics. He has worked as Business Director and Country Manager responsible for P&L and sales operations in the
Central East Europe
is the first and only product on the market to allow efficient testing of infectious diseases at the point-of care.
ArcDia has during the last couple of years participated
the most relevant trade fairs and congresses, and as late as
was presented at the Arab Health in
with a huge interest from both potential distributors and end-users. I am excit
to join the ArcDia team and to expand mariPOC
business in the international markets
, VP Sales and Marketing, ArcDia Ltd.
We are pleased to welcome Mr.
Kristiansen to join the ArcDia team. He brings his experi
ce and knowledge in international sales of IVD pr
to build up the distribut
and customer operations
, says Dr.
, CEO of ArcDia Ltd.
Earlier in 2012, ArcDia announced collaboration agreement with Laboratories LETI for
. ArcDia's products have been in daily clinical practice since 2011.
provides multianalyte diagnostic results for influenza like illnesses and tonsillitis in near patient settings in 20 minutes. The mariPOC
applications are targeted to acute respiratory infections, which represents the most common infectious diseases on Earth.
is superior in performance to the conventional test methods, including lateral flow rapid tests and standard culturing. mariPOC
is designed to improve patient management, quality of health care, and to allow pathogen specific timely diagnostics and medication to all patients. mariPOC
was launched to the European market in late 2010.